XML 60 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Investment in RP Finance, LLC (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Oct. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Nov. 30, 2020
Aug. 31, 2020
Feb. 03, 2020
Investment in RP Finance, LLC (Details) [Line Items]                
Amount of revolving commitment to funds     $ 10,000 $ 5,000 $ 10,000 $ 5,000 $ 5,000  
Income from interest   $ 383            
Cumulative funds description   As of July 31, 2022, the Company has funded a cumulative total of $9.375 million in accordance with its 37.5% ownership interests in RP Finance.            
Reserve on related party interest receivable of Interest income, net   $ 1,900            
Rafael Pharmaceuticals [Member]                
Investment in RP Finance, LLC (Details) [Line Items]                
Amount of revolving commitment to funds       $ 5,000   $ 5,000 $ 5,000  
Percentage of issued and outstanding shares   12.00%            
Related party receivable   $ 9,375            
RP Finance [Member]                
Investment in RP Finance, LLC (Details) [Line Items]                
Income from interest   $ 575            
Percentage of ownership interest   37.50% 37.50%          
Equity loss $ 575              
Equity method investment   $ 0            
Line of Credit Agreement [Member]                
Investment in RP Finance, LLC (Details) [Line Items]                
Amount of revolving commitment to funds               $ 50,000,000
Description line of credit facility   The Company owns 37.5% of the equity interests in RP Finance and is required to fund 37.5% of funding requests from Cornerstone Pharmaceuticals under the RPF Line of Credit. Howard Jonas owns 37.5% of the equity interests in RP Finance, and is required to fund 37.5% of funding requests from Cornerstone Pharmaceuticals under the RPF Line of Credit. The remaining 25% equity interests in RP Finance are owned by other shareholders of Cornerstone Pharmaceuticals.